METTL27 is a prognostic biomarker of colon cancer and associated with immune invasion.
10.12122/j.issn.1673-4254.2022.04.04
- Author:
Kang WANG
1
;
Jun ZHANG
1
;
Mu Wen DENG
1
;
Yong Le JU
1
;
Man Zhao OUYANG
1
Author Information
1. Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University, Foshan 528308, China.
- Publication Type:Journal Article
- Keywords:
bioinformatics;
clinical prognosis;
colon cancer;
immune infiltration;
methyltransferase-like protein 27
- MeSH:
Colonic Neoplasms/pathology*;
Humans;
Kaplan-Meier Estimate;
Prognosis;
RNA, Messenger
- From:
Journal of Southern Medical University
2022;42(4):486-497
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the expression and gene function of methyltransferase-like protein 27 (METTL27) in colon cancer, its association with immune infiltration and its prognostic significance.
METHODS:We analyzed the expression levels of METTL27 in 33 cancers using R language and identified METTL27 as a differential gene in colon cancer. The related signaling pathways of METTL27 were analyzed by gene functional annotation and enrichment. SsGSEA algorithm was used to analyze immune infiltration, and logistic analysis was used to evaluate the correlation between METTL27 expression and clinicopathological features of the patients. Kaplan-meier analysis, univariate and multivariate Cox regression analysis were performed to construct a nomogram for evaluating the correlation between METTL27 expression and clinical prognosis. The expression level of METTL27 was further verified in colorectal cancer cell lines and 16 clinical specimens of colorectal cancer tissues using qPCR and Western blotting.
RESULTS:METTL27 was highly expressed in 21 cancers, and its expression was significantly higher in colon cancer than in adjacent tissues (P < 0.001). METTL27-related genes were identified by differential analysis, and functional annotation revealed that METTL27 was significantly enriched in transmembrane transport and lipid metabolism, and 5 related signaling pathways were identified by GSEA. METTL27 expression was negatively correlated with different T helper cells and central memory T cells (P < 0.001). The patients with a high METTL27 mRNA expression had a poor survival outcome. Cox regression analysis showed that METTL27 expression was an independent prognostic factor of the overall survival. The expression level of METTL27 was significantly higher in the colorectal cancer cell line than in normal cells (P < 0.05).
CONCLUSION:METTL27 is overexpressed in colon cancer and is associated with a poor prognosis of the patients. A high expression of METTL27 showed is associated less T cell immune infiltration, suggesting the potential of METTL27 as a prognostic marker of colon cancer.
